FGF-21 expression or analogs counteract metabolic disorders, inflammation and fibrosis in the liver,[65], [66], [67] while FGF-21 can have oncogenic activity in various cancers.[68], [69], [70]. This evidence concerns the gene FGF21 and metabolic disease.